AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 61 filers reported holding AC IMMUNE SA in Q2 2021. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $447,777 | +160393.5% | 151,532 | +27.3% | 0.00% | – |
Q1 2023 | $279 | +25.7% | 119,027 | +9.4% | 0.00% | – |
Q4 2022 | $222 | -99.9% | 108,806 | +169.0% | 0.00% | – |
Q3 2021 | $271,000 | -55.4% | 40,452 | -47.2% | 0.00% | – |
Q2 2021 | $607,000 | -68.4% | 76,569 | -69.6% | 0.00% | -100.0% |
Q1 2021 | $1,918,000 | +1659.6% | 252,026 | +1092.2% | 0.00% | – |
Q4 2020 | $109,000 | -95.3% | 21,140 | -95.5% | 0.00% | -100.0% |
Q3 2020 | $2,314,000 | -33.5% | 474,129 | -8.3% | 0.00% | -40.0% |
Q2 2020 | $3,481,000 | -4.2% | 517,236 | -1.6% | 0.01% | -37.5% |
Q1 2020 | $3,632,000 | +752.6% | 525,679 | +951.8% | 0.01% | +700.0% |
Q4 2019 | $426,000 | -29.8% | 49,978 | -59.3% | 0.00% | 0.0% |
Q3 2019 | $607,000 | -51.6% | 122,806 | -45.7% | 0.00% | -50.0% |
Q2 2019 | $1,254,000 | +46.3% | 225,974 | +33.1% | 0.00% | +100.0% |
Q1 2019 | $857,000 | -32.7% | 169,759 | +38.1% | 0.00% | -50.0% |
Q1 2017 | $1,273,000 | +33.4% | 122,924 | +67.2% | 0.00% | 0.0% |
Q4 2016 | $954,000 | +11.2% | 73,530 | +41.1% | 0.00% | +100.0% |
Q3 2016 | $858,000 | – | 52,121 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 7,428,379 | $21,170,880 | 0.57% |
Avidity Partners Management LP | 2,969,800 | $8,463,930 | 0.34% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,322,462 | $3,769,017 | 0.15% |
Eversept Partners, LP | 124,589 | $355,079 | 0.03% |
COHEN LAWRENCE B | 12,850 | $36,623 | 0.02% |
Banque Cantonale Vaudoise | 80,701 | $231 | 0.01% |
Renaissance Technologies | 425,179 | $1,212 | 0.00% |
Handelsbanken Fonder AB | 101,064 | $288 | 0.00% |
Tower Research Capital LLC (TRC) | 19,638 | $55,968 | 0.00% |
Compagnie Lombard Odier SCmA | 10,000 | $28,500 | 0.00% |